🔓 Unlock the full profile of Keith Lenden (Arch Venture Partners), including verified contact details, financial insights, and professional associations.
See Keith Lenden Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: kei*****@arc******.com
Mobile: 95146*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Keith Lenden is a co-founder of multiple biotechnology companies, demonstrating a significant entrepreneurial spirit and expertise in the life sciences sector.
- Currently, Keith serves as a Co-Founder at ARCH Venture Partners, an organization founded in 1986 that focuses on early-stage venture capital investments in technology and life sciences.
- Keith also co-founded Autobahn Therapeutics, Inc. in February 2018, contributing to advancements in therapeutic solutions.
- As a co-founder of Boundless Bio, established in July 2018, Keith is engaged in innovative research and development efforts aimed at transforming cancer treatment.
- Previously, Keith co-founded Abide Therapeutics in January 2011, which emphasized the role of lysophosphatidic acid receptors in medical therapy.
- At Receptos, another co-founded venture from August 2008 until August 2015, Keith played a crucial role in furthering research on immunology and autoimmune diseases.
- Earlier in their career, Keith worked as a Senior Director of Business Development at Acologix, starting in October 2004, showcasing skills in strategic growth and partnership formation.
- Keith's career began in consulting at LEK Consulting from 1995 to 1999, laying a foundation in strategic analysis and market evaluation relevant to the biotech field.